- Home
- INVA vs NUV Comparison
INVA vs NUV Comparison
Compare INVA & NUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$23.61
Company Overview
Basic Information| Metric | INVA | NUV |
|---|---|---|
| Founded | 1996 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | INVA | NUV |
|---|---|---|
| Price | $23.61 | $9.15 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 522.3K | 495.6K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.96% |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 3.30 | N/A |
| Revenue | ★ $217,217,000.00 | N/A |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $12.65 | N/A |
| P/E Ratio | $7.08 | ★ N/A |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $16.52 | $8.45 |
| 52 Week High | $25.15 | $9.26 |
Technical Indicators
Market Signals| Indicator | INVA | NUV |
|---|---|---|
| Relative Strength Index (RSI) | 53.81 | 52.00 |
| Support Level | $23.28 | $9.12 |
| Resistance Level | $24.45 | $9.24 |
| Average True Range (ATR) | 0.63 | 0.05 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 39.24 | 53.33 |
Price Performance
Historical Comparison INVA
NUV
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
About NUV Nuveen Municipal Value Fund Inc.
Nuveen Municipal Value Fund Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide current income exempt from regular federal income tax. The Fund's secondary investment objective is to enhance portfolio value and total return.